header logo image

Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France

November 26th, 2023 2:53 am

Bagsværd, Denmark, 23 November 2023 – Novo Nordisk today announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases.

Read more:
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick